Investor Relations

    Sernova Corp.

    Sernova was founded 2006 in London, Ontario; (TSX(v); SVA.V)

    Sernova is a clinical-stage company developing products for the treatment of chronic debilitating diseases using therapeutic cells transplanted into an implanted medical device, the Cell Pouch™. The Cell Pouch™ forms a natural environment for the long-term survival and function of the therapeutic cells which release needed proteins or hormones. The company’s first products are for the treatment of insulin-dependent diabetes.

    Sernova’s Cell Pouch™, combined with its Sertolin™ local immune protection technology, offers therapeutic cells local protection from immune system attack creating an effective, safe, long-term and convenient therapeutic option for patients with chronic disease who seek to improve their quality of life.

    Video and Presentation

    Watch videos and presentations online

    June 21, 2016

    Sernova Fact Sheet

    June 21, 2016

    Sernova's 2016 Corporate Presentation

    PDF Presentation

    Stock Price

    Last Updated: 10:07am

    Latest Price: $0.255

    Symbol: SVA.V

    Change: +0.010 (+4.082%)

    Volume: 71000

    For historical charts please visit:

    Please Note: All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Sernova nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.